Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANGONG TRIAL: Angong Niuhuang Pill in Acute Ischemic Stroke
NCT04475328Phase 3Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Oct 2020
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Angong Niuhuang Pill in ischemic stroke, sponsored by Peking Union Medical College Hospital. Started Oct 2020; status: completed.
02
Drugs
Angong Niuhuang Pill
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04475328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04475328.